Study finds most patients in TARGET-NASH registry meet revised MASLD criteria – Pharmaceutical Technology
Image credit: Shutterstock/Peakstock Analytics firm Target RWE has published its findings that 99% of participants in TARGET-NASH, a research registry of patients with nonalcoholic fatty